Abstract:The double-stranded DNA (dsDNA) viruses represented by adenovirus and monkeypox virus, have attracted widespread attention due to their high infectivity. In 2022, the global outbreak of mpox (or monkeypox) has led to the declaration of a Public Health Emergency of International Concern. However, to date therapeutics approved for dsDNA virus infections remain limited and there are still no available treatments for some of these diseases. The development of new therapies for treating dsDNA infection is in urgent need. In this study, we designed and synthesized a series of novel disulfide-incorporated lipid conjugates of cidofovir (CDV) as potential candidates against dsDNA viruses including vaccinia virus (VACV) and adenovirus (AdV) 5. The structure-activity relationship analyses revealed that the optimum linker moiety was C2H4 and the optimum aliphatic chain length was 18 or 20 atoms. Among the synthesized conjugates, 1c exhibited more potency against VACV (IC50 = 0.0960 μM in Vero cells; IC50 = 0.0790 μM in A549 cells) and AdV5 (IC50 = 0.1572 μM in A549 cells) than brincidofovir (BCV). The transmission electron microscopy (TEM) images revealed that the conjugates could form micelles in phosphate buffer. The stability studies in the GSH environment demonstrated that the formation of micelles in phosphate buffer might protect the disulfide bond from glutathione (GSH) reduction. The dominant means of the synthetic conjugates to liberate the parent drug CDV was by enzymatic hydrolysis. Furthermore, the synthetic conjugates remained sufficiently stable in simulated gastric fluid (SGF), simulated intestinal fluid (SIF), and pooled human plasma, which indicated the possibility for oral administration. These results indicated 1c may be a broad-spectrum antiviral candidate against dsDNA viruses with potential oral administration. Moreover, modification of the aliphatic chain attached to the nucleoside phosphonate group was involved as an efficient prodrug strategy for the development of potent antiviral candidates.

Novel Mutual Pro-Drugs of 2′,3′-Dideoxyinosine with 3-Octadecyloxy-propane-1,2-diol by Straightforward Enzymatic Regioselective Synthesis in Acetone

Screening Novel HIV-1 Protease Inhibitors Based on the Substrate Envelope Hypothesis

Synthesis of C18–C28 ketone fragment of micromonospolide B possessing 1,3-diene and 1,3-anti-diol functionalities

Synthesis and Anti‐HIV Activity of a Series of 6‐modified 2′,3′‐dideoxyguanosine and 2′,3′‐didehydro‐2′,3′‐dideoxyguanosine Analogs

Synthesis of Novel 5′-Hydrogenphosphonothioate Derivatives of AZT, d4T and ddI

Synthesis of Novel Dimeric Steroidal-nucleoside Phosphoramidates

Facile synthesis of novel mutual derivatives of nucleosides and pyrimidines by regioselectively chemo-enzymatic protocol.

The synthesis of amphipathic prodrugs of 1,2-diol drugs with saccharide conjugates by high regioselective enzymatic protocol.

Study On Synthesis Of Ethyl 3-Oxo-(+/-)-6,7-Di-O-Isopropylidene-6,7-Dihydroxyheptanoate

Controllable Regioselective Enzymatic Synthesis of Polymerizable 5′-O-vinyl- and 3′-O-vinyl-nucleoside Analogues in Acetone

One-pot Synthesis of the O-(3-Diosgenin) O′-[5′-(3′-Azido-3′-deoxythymidine)]-H-phosphonate

Synthesis and Antiviral Evaluation of 3'- C -Hydroxymethyl-3'- O -Phosphonomethyl-β-D-5'-deoxyxylose Nucleosides

A new approach for the asymmetric syntheses of 2-epi-deoxoprosopinine and azasugar derivatives

Synthesis and Anti-HIV-1 Activity Evaluation of 5-Alkyl-2-alkylthio-6-(arylcarbonyl or Α-Cyanoarylmethyl)-3,4-dihydropyrimidin-4(3h)-ones As Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Disulfide-incorporated lipid prodrugs of cidofovir: Synthesis, antiviral activity, and release mechanism

Anti-AIDS Agents 86. Synthesis and Anti-Hiv Evaluation of 2′,3′-Seco-3′-nor DCP and DCK Analogues

Study on Synthesis of Ethyl 3-Oxo-(s)-(+)-6,7-di-o- Isopropylidene-6,7-Dihydroxyheptanoate

Two-step Synthesis of Structure-Diverse D-Galactose Conjugates and Polymeric Prodrugs of Floxuridine Via Controllable Regioselective Enzymatic Acylation of 3′- or 5′-OH Group of Floxuridine

Synthesis and Biological Evaluation of Novel N-[3-(4-phenylpip-erazin-1-yl)-propyl]-carboxamide Derivatives

Symmetrical Phosphinic Acids: Synthesis and Esterification Optimization toward Potential HIV Prodrugs

One-Pot Synthesis of N-1,3-Dihydroxyprop-2-Ylalkylacetamide